Major Studies, Novel Talks Highlight ASH MedPage Today Another presentation will reveal final results from a large, international phase III trial to compare obinutuzumab (Gazyva) and rituximab (Rituxan), each paired with chlorambucil, in patients with CLL and significant comorbid medical conditions. "Both ... |
